Biotech Transfer Week GenomeWeb News Premium Content Existing subscribers login here. Biotech Transfer Week is Now FREE - Everyone Can Subscribe!

Orion Genomics Licenses Epigenetic Marker
From JHU to Develop Early-Stage CRC Test

[June 11, 2008]

By Ben Butkus

The license will allow Orion to develop a blood test based on IGF2 imprinting abnormalities that would identify at-risk patients at a much younger age than current tests so they can be screened for the disease at its earliest stages using existing techniques.

Login | Subscribe